<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/EAAD4D43-BD15-432B-9385-2DBD0C65958D"><gtr:id>EAAD4D43-BD15-432B-9385-2DBD0C65958D</gtr:id><gtr:name>University of Bath</gtr:name><gtr:department>Pharmacy and Pharmacology</gtr:department><gtr:address><gtr:line1>University of Bath</gtr:line1><gtr:line2>Claverton Down</gtr:line2><gtr:line4>Bath</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BA2 7AY</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EAAD4D43-BD15-432B-9385-2DBD0C65958D"><gtr:id>EAAD4D43-BD15-432B-9385-2DBD0C65958D</gtr:id><gtr:name>University of Bath</gtr:name><gtr:address><gtr:line1>University of Bath</gtr:line1><gtr:line2>Claverton Down</gtr:line2><gtr:line4>Bath</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BA2 7AY</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/82E3EE22-3CA3-4885-AB99-F1969C2C69A2"><gtr:id>82E3EE22-3CA3-4885-AB99-F1969C2C69A2</gtr:id><gtr:firstName>Charareh</gtr:firstName><gtr:surname>Pourzand</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FJ005223%2F1"><gtr:id>B3636371-C118-4963-89FF-9604F1941ADB</gtr:id><gtr:title>Mitochondrial- and lysosomal-targeted iron chelators for the monitoring and adjustment of cellular labile iron pools</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/J005223/1</gtr:grantReference><gtr:abstractText>Iron in the body is necessary for a series of vital functions. The chemical nature of iron makes it highly reactive, and this reactivity can be both useful and potentially harmful. Iron plays its most obvious positive role in the oxygen-carrying protein, haemoglobin, in the blood. However, iron can do damage through stimulating the formation of reactive oxygen species (ROS). These in turn generate 'oxidative stress' and modify cellular components such as proteins, fats and DNA, bringing about abnormal cell function, including possible death. Cells have evolved protective anti-oxidant mechanisms to counter these effects; however excess iron can overcome these mechanisms. In order to induce this damaging effect, iron has to be present in cells in a 'free' form, i.e. not tightly bound by other molecules. Levels of 'free' iron are generally kept very low by the presence of proteins, particularly ferritin, that bind the iron and prevent it from stimulating ROS formation. However recent studies have shown that despite these iron trapping proteins, there is a significant amount of free iron in distinct cell compartments (e.g. mitochondrial and lysosomal organelles) of healthy cells that render them susceptible to oxidative damage and cell death especially in presence of ROS or upon exposure to environmental oxidising agents such as sunlight that generate ROS. Because of the harmful role of free iron, iron trapping drugs (i.e. 'iron chelators') have been proposed as a means to remove excess iron from these subcellular compartments that is detrimental in oxidative stress conditions. Unfortunately the effectiveness of current iron chelators to counteract these effects is much reduced because they have either low permeability and therefore are unable to access their intracellular targets or are highly permeable and therefore upon administration non-specifically diffuse in all cell compartments and cause systemic iron starvation and toxicity. Much effort has gone into the development of novel subcellular organelle-specific iron-chelator drug design strategies to alleviate these problems, but with little success. There is therefore a clear need to develop smart iron chelators that could be specifically delivered to subcellular compartments, where they could register and remove potentially harmful excess iron. We have recently developed a promising iron chelator called HPO-20 that exclusively monitors the free iron content in lysosomal organelles. The high selectivity of HPO-20 for lysosomes represents a considerable step forward toward sensitive evaluation of free iron distribution in subcellular compartments under normal and oxidative stress conditions. However based on current literature, there is no such exclusive equivalent compound for monitoring free iron in mitochondrial compartment. In the present project, we propose to design a series of novel protective mitochondria-specific iron chelators that upon administration directly reach the targeted subcellular compartment. These novel compounds are unique in that they provide the possibility to register and remove potentially harmful residual iron in the organelle. So they have the potential to be used either as biological diagnostics tools or as protective agents. For example our compounds have potential to prevent iron-related oxidative injuries caused by harmful environmental agents notably skin damage caused by sunlight. So in the long term they have potential to be used as photoprotective ingredients in sunscreen formulations and to decrease dramatically the sun-related skin cancer. The possibility of monitoring lysosomal and mitochondrial free iron content with our compounds will also help the identification of pathologies related to subcellular iron-misdistribution. Therefore our compounds will have a major long term impact on public health through availability of combined diagnostic and preventive regimes.</gtr:abstractText><gtr:technicalSummary>Recent cellular studies have indicated that mitochondrial and lysosomal redox active and chelatable labile iron (LI) plays a key role in conferring cellular sensitivity to oxidative damage and the resulting pathologies and cell death. The design of organelle-targeted iron sensors for sensitive evaluations of LI distribution in lysosomal and mitochondrial subcellular compartments appears therefore to be an essential prerequisite for development of highly targeted iron chelators as preventive agents for iron-related oxidative injuries. Recently we have developed a promising HPO-based fluorescent iron III sensor (HPO-20) that exclusively monitors LIP in the lysosomal compartment. However based on current literature, there is no such exclusive equivalent compound for monitoring LI in mitochondrial compartment. This proposal responds primarily to the urgent need to develop highly specific mitochondria-targeted fluorescent iron chelators to be used both as biological probes to evaluate intra-mitochondrial LI and as mitochondria-specific iron chelators to selectively remove potentially harmful LI from mitochondria. To achieve high specificity, we plan to modify a series of fluorescent iron chelators by linking them to specific mitochondrial-homing peptides that can effect targeted delivery directed to mitochondria. The specificity, mode of action and protective properties of these mitochondrial iron sensors/chelators will be evaluated in a series of specific cell lines exposed or not to oxidising agents. The subcellular LI distribution in mitochondria, lysosomes and cytosol and subcellular LI trafficking under normal and oxidative stress conditions will also be evaluated in these cell lines. With no adequate organelle-specific iron sensors/chelators available, our compounds are expected to be of significant value to both biological and pre-clinical research as powerful biological probes and as highly specific preventive agents against iron-related oxidative injuries.</gtr:technicalSummary><gtr:potentialImpactText>The present project will deliver a series of novel compounds capable of registering and removing excess free iron from subcellular organelles, which is detrimental in oxidative injuries and pathologies. Therefore the outputs of this project will have potential for a wide range of applications. In the short term these compounds may be used as research tools to advance knowledge in a wide range of iron-related biological and pre-clinical disciplines. This would provide strategies towards diagnosis, prognosis and treatment of disorders of excess iron and misdistribution. So in the long term these compounds will have potential for clinical use as diagnostics/ prognostics markers or medicaments for therapy. 
Potential stakeholders - Academia/Research organisations and clinical services; Public sector organisations notably Department of Health and NHS; Pharmaceutical/Biotech companies; General Public. These stakeholders may benefit in the following ways: 
Health Benefits - Currently there is no satisfactory drugs for prevention of iron-catalysed oxidative injuries and pathologies notably cancer, psoriasis, rheumatoid arthritis, Parkinson's disease and Friedreich's ataxia. Most of the currently applied therapeutic modalities for these diseases are associated with severe side effects and discomfort for the patients. Our proposed compounds are unique in that they provide a means of non-damaging targeted delivery of the drug to diseased cells. Furthermore they are designed to act both as biological probes to register the iron of the diseased cells and as medicaments to remove the potentially harmful excess iron. Our compounds are therefore likely to have a major long term impact on public heath through availability of combined diagnostic/prognostic and therapeutic regimes involving high selectivity, reduced side effects and corresponding improved patient compliance and quality of life for a wide range of disorders. Furthermore our compounds have potential to prevent iron-related oxidative injuries notably skin damage caused by sunlight. So in the long term they have potential to be used as photoprotective ingredients in sunscreen formulations. Given the high incidence of sun-related skin cancer in UK and the fact that its mortality rate is increasing globally, our compounds as sun-protective agents could also have a high long term impact on general public health and well-being. The more accurate diagnostics/prognostics tests with highly specific and targeted treatment for such a wide range of iron-related disorders will allow more rapid patient profiling and quicker administration of specific treatments that will benefit the general public for improved treatments and better patient outcomes. This is likely to benefit Department of Health (DOH), NHS and clinicians for improved healthcare delivery. The early diagnosis and treatment of diseases may even in the long run influence the public sector organisations (DOH, NHS) through reduction of healthcare delivery. 
Commercial and Economic benefits - The compounds developed in the proposed project will be of significant benefit to pharmaceutical sector, providing new potential candidate drugs for pre-clinical development and new ingredients for skin photoprotection. Diagnostics companies will benefit from being able to develop and commercialise iron-related disease test kits as biological research probes and clinical diagnostics/prognostics tools. This will maximise scientific advancement and wealth creation in a UK (i.e. value added to UK economy) and international (inward investment) context. Furthermore the availability of such diagnostic/prognostic kits could help clinicians with early diagnosis of the disease and as such to decrease considerably the costs related to advanced disease treatment modalities. This will in turn have an economical impact on DOH, NHS and private medical providers through cost reductions in delivery of healthcare services.</gtr:potentialImpactText><gtr:fund><gtr:end>2015-04-02</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2012-04-03</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>286449</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>4 Conference contributions in 2015 ( 2 in 6th International BioIron Society 2015, Hangzhou, China; 2 in 6th World Mitochondria Society conference on 'Targeting Mitochondria', 2015, Berlin, Germany.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>EA185ADB-3535-48EE-BA63-95349979E831</gtr:id><gtr:impact>four published conference proceedings.</gtr:impact><gtr:outcomeId>56dda5ad80cc62.80887119</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.bioIron.org</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Conference contribution: Fifth Congress of the International BioIron Society (IBIS), 2013-04-13 - 2013-04-17, London</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>547C07A6-6C18-4DD0-B738-75F02A339184</gtr:id><gtr:impact>Abstract entitled ' MITOCHONDRIA-TARGETED IRONCHELATORS FOR THE MONITORING AND ADJUSTMENT OF CELLULAR LABILE IRON POOLS' was presented as a poster in the 'Fifth Congress of the International BioIron Society (IBIS) meeting from April 14-18, 2013 in UCL, London, United Kingdom'. Authors: Vincenzo Abbate1*, Robert C. Hider1, Charareh Pourzand2 and Olivier Reelfs2, 
1King's College London; 2Department of Pharmacy and Pharmacology, University of Bath.
The synopsis of the poster was selected for a further short presentation during the conference. The abstract was then published in American Journal of Haematology,

no actual impacts realised to date</gtr:impact><gtr:outcomeId>r-5644028434.1983760cc1e4fa</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:url>http://opus.bath.ac.uk/34165/</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Press Release</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>29B056EF-1D02-4A97-B2D5-87196AA38964</gtr:id><gtr:impact>University of Bath press release with the purpose to disseminate the findings of our group and the impact they may have on human well-being.
Impacts that have arisen: Subsequently this resulted in national and international media coverage as listed below:

- https://twitter.com/research_uk/status/756030974190845952
- http://www.bbsrc.ac.uk/news/health/2016/160720-pr-sun-cream-offers-unprecedented-protection/ (Will also likely go in BBSRC Business magazine)
- http://www.bathecho.co.uk/news/health/bath-uni-scientists-create-new-sun-cream-protection-uva-radiation-68043/
- http://www.eurekalert.org/pub_releases/2016-07/uob-nsc072016.php
- http://medicalxpress.com/news/2016-07-sun-cream-compound-unprecedented-uva.html
- http://www.sciencenewsline.com/summary/2016072021110070.html
- http://dailyme.com/story/2016072100000510/new-sun-cream-compound-offers-unprecedented-protection-against-uva-radiation-sciencedaily
- http://www.news-medical.net/news/20160720/New-Sun-Cream-Compound-Offers-Unprecedented-Protection-Against-UVA-Radiation.aspx
- https://www.sciencedaily.com/releases/2016/07/160720105042.htm
- http://www.healthcanal.com/skin-hair-nails/73990-new-sun-cream-compound-offers-unprecedented-protection-against-uva-radiation.html
- http://www.newswise.com/articles/view/657600/?sc=rsla
- http://newswise.com/articles/new-sun-cream-compound-offers-unprecedented-protection-against-uva-radiation
- http://www.newkerala.com/news/2016/fullnews-93494.html
- http://www.business-standard.com/article/pti-stories/new-sunscreen-compound-protects-against-uva-radiation-116072100787_1.html
- http://www.business-standard.com/article/news-ians/novel-sunscreen-compound-to-prevent-uv-a-radiation-developed-116072100583_1.html
- http://www.5dariyanews.com/news/157837-Novel-sunscreen-compound-to-prevent-UV-A-radiation-developed
- http://news.indiaonline.in/Novel-sunscreen-compound-to-prevent-UV-A-radiation-developed-1316795
- http://www.medicalnewstoday.com/articles/311820.php 
- http://scienmag.com/new-sun-cream-compound-offers-unprecedented-protection-against-uva-radiation/
- http://www.canindia.com/novel-sunscreen-compound-to-prevent-uv-a-radiation-developed/
- http://citizensjournal.us/new-sunscreen-compound-protects-your-cells-from-uva-damage/
- http://www.mideastclinics.com/healthNews/116844/UCF/New-sunscreen-compound-protects-against-UVA-induced-skin-aging%2C-cancer.html#.V5Ha2OsrJhE
- http://netindia123.com/netindia/showdetails.asp?id=2903882&amp;amp;n_date=20160721&amp;amp;cat=Health
- http://www.stonehearthnewsletters.com/new-sun-cream-compound-offers-unprecedented-protection-against-uva-radiation/skin-cancer/
- http://www.thesouthasiantimes.info/index.php?param=news/139700
- https://in.news.yahoo.com/novel-sunscreen-compound-prevent-uv-radiation-developed-090803345.html?nhp=1
- http://chattahbox.com/health/2016/07/20/new-sun-cream-compound-offers-unprecedented-protection-against-uva-radiation/
- http://www.bionity.com/en/news/159038/new-sun-cream-compound-offers-unprecedented-protection-against-uva-radiation.html
- http://www.financialexpress.com/lifestyle/science/new-sunscreen-compound-protects-against-uva-radiation/324767/
- http://www.news-line.com/PL_news25157_
- http://myinforms.com/en-us/a/38720046-new-wonder-compound-offers-strong-protection-against-harmful-effects-of-uva-rays/
- http://www.themalaymailonline.com/features/article/scientists-develop-new-super-cream-that-offers-strong-uva-sun-protection
- http://www.physiciansbriefing.com/Article.asp?AID=713255
- http://www.doctorslounge.com/index.php/news/pb/65394
- http://uproxx.com/life/sunscreen-uva-protection/
Australia:
- http://www.infobek.com/view.php?tur=21&amp;amp;id=75299
South Asia:
- http://www.thesouthasiantimes.info/index.php?param=news/139700
- https://in.news.yahoo.com/novel-sunscreen-compound-prevent-uv-radiation-developed-090803345.html?nhp=1
Canada:
- https://fr.news.yahoo.com/cr%C3%A8me-solaire-d%C3%A9couverte-dune-mol%C3%A9cule-140300734.html
- http://www.innovationtoronto.com/2016/08/sun-cream-compound-offers-unprecedented-protection-against-uva-radiation/
Singapure:
- http://www.msn.com/en-sg/news/newsother/scientists-have-invented-a-new-way-to-stop-skin-damage-and-aging-caused-by-the-sun/ar-BBv6XCR?li=BBr8Mkh
France:
- http://www.lesoir.be/1273597/article/victoire/beaute-bien-etre/2016-07-22/cremes-solaires-decouverte-d-une-molecule-ultraresistante-aux-uva 
- http://www.lamontagne.fr/france-monde/actualites/societe/sante-beaute/2016/07/22/creme-solaire-une-molecule-ultraresistante-aux-uva-devoilee_12011679.html 
- http://www.lyonne.fr/france-monde/actualites/societe/sante-beaute/2016/07/22/creme-solaire-une-molecule-ultraresistante-aux-uva-devoilee_12011679.html
- http://www.ladepeche.fr/article/2016/07/22/2389313-creme-solaire-une-molecule-ultraresistante-aux-uva-devoilee.html
- http://www.leparisien.fr/laparisienne/sante/creme-solaire-une-molecule-ultraresistante-aux-uva-devoilee-22-07-2016-5987569.php
- http://www.msn.com/fr-ca/actualites/science-et-techno/cr%C3%A8mes-solaires-%C3%A0-la-d%C3%A9couverte-d%E2%80%99une-mol%C3%A9cule-ultrar%C3%A9sistante-aux-uva/ar-BBuFgcC
- http://nt.interia.pl/technauka/news-rmf-24-bezpieczniej-na-sloncu,nId,2240917
- https://fr.news.yahoo.com/cr%C3%A8me-solaire-d%C3%A9couverte-dune-mol%C3%A9cule-140300734.html
- http://www.topsante.com/beaute-et-soins/solaire-bronzage/protection-solaire/creme-solaire-decouverte-d-une-molecule-hyper-resistante-aux-uva-612495
- http://www.24matins.fr/protection-solaire-nouvelle-molecule-resistante-aux-uva-368768
- http://www.ouest-france.fr/sante/cancer-de-la-peau-mise-au-point-dune-molecule-resistante-aux-uva-4387814
- http://www.pourquoidocteur.fr/Articles/Question-d-actu/16901-Creme-solaire-decouverte-d-une-molecule-resistante-aux-rayons-UVA
- http://www.observatoiredescosmetiques.com/actualite/publications-scientifiques/une-protection-inedite-contre-les-uva-bientot-dans-nos-cremes-solaires%C2%A0-4021
- http://www.bibamagazine.fr/style-de-vie/sante/solaires-bientot-une-super-protection-contre-les-uva-58560
- http://www.femmeactuelle.fr/sante/news-sante/creme-solaire-decouverte-molecule-contre-uva-31644
- http://sixactualites.fr/actualites/nexisterait-aucune-protection-solaire-completement-efficace-actuellement/29963/
- http://www.pourquoidocteur.fr/Articles/Question-d-actu/16926-Creme-solaire-une-nouvelle-molecule-protege-des-rayons-UVA
- http://portail.free.fr/actualites/france/6485797_20160726_protection-solaire-une-nouvelle-molecule-resistante-aux-uva.html 
- http://www.metronews.fr/info/protection-solaire-ce-nouveau-compose-bloque-les-uva-responsables-du-cancer-de-la-peau/mpgz!HZGrWWEFQHNCU/
- https://fr.news.yahoo.com/cancer-peau-griffe-mitoiron-super-mol%C3%A9cule-r%C3%A9sistante-uva-100928248.html?nhp=1
- http://www.20minutes.fr/sante/1900135-20160727-cancer-peau-griffe-mitoiron-super-molecule-resistante-uva
- http://www.francesoir.fr/societe-sante/protection-solaire-une-molecule-pour-contrer-les-uva-ete-mise-au-point
- http://feminactu.com/2016/07/cremes-solaires-un-nouveau-compose-pour-bloquer-les-uva/
Arabic:
- http://almadapaper.net/ar/news/513809/%D8%B5%D8%AD%D8%AA%D9%83--3
- http://www.3yonnews.com/news/25/999198/%D8%A8%D8%A7%D8%AD%D8%AB%D9%88%D9%86_%D9%8A%D8%B7%D9%88%D8%B1%D9%88%D9%86_%D8%B9%D9%84%D8%A7%D8%AC%D9%8B%D8%A7_%D9%8A%D8%AD%D9%85%D9%89_%D9%85%D9%86_%D8%AA%D9%84%D9%81_%D8%A7%D9%84%D8%AC%D9%84%D8%AF
- http://www.elhadas.com/beauty/88223.html
- http://www.landfun.net/health/23489.html
- http://akhbarcairo.com/health/172993.html
- http://elgornal.net/news/news.aspx?id=8781334
- http://www.youm7.com/story/2016/7/23/%D8%A8%D8%A7%D8%AD%D8%AB%D9%88%D9%86-%D9%8A%D8%B7%D9%88%D8%B1%D9%88%D9%86-%D8%B9%D9%84%D8%A7%D8%AC%D9%8B%D8%A7-%D9%8A%D8%AD%D9%85%D9%89-%D9%85%D9%86-%D8%AA%D9%84%D9%81-%D8%A7%D9%84%D8%AC%D9%84%D8%AF/2811462
-Polland: http://www.termedia.pl/dermatologia/Mozliwe-bezpieczniejsze-opalanie-Brytyjscy-naukowcy-uwazaja-ze-tak-,22954.html

Additional impact: The press release attracted the interest of several international cosmetic companies which are currently negotiating potential collaborations with our team.</gtr:impact><gtr:outcomeId>58c1944c26beb5.71333622</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.bath.ac.uk/news/2016/07/20/sun-cream-uva/</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Radio interview with BBC Bristol.</gtr:description><gtr:form>A broadcast e.g. TV/radio/film/podcast (other than news/press)</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F2F98B21-C52E-4902-A8F8-536F3084DAE0</gtr:id><gtr:impact>Dr Olivier Reelfs was interviewed by BBC Bristol.</gtr:impact><gtr:outcomeId>58c1955c49d112.86519436</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Radio interview with Radio Heart.</gtr:description><gtr:form>A broadcast e.g. TV/radio/film/podcast (other than news/press)</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>5ACC6E0C-3D8F-4D72-BB38-3E76E3AAA0C2</gtr:id><gtr:impact>Dissemination of the findings of the project to the general public via an invited radio interview with Radio Heart.</gtr:impact><gtr:outcomeId>58c198c3eef481.21786044</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Radio interview with BBC Wiltshire.</gtr:description><gtr:form>A broadcast e.g. TV/radio/film/podcast (other than news/press)</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D657504D-6ECD-41D9-B617-1A330E545FD2</gtr:id><gtr:impact>Dissemination of the findings of the project to the general public via an invited radio interview with BBC radio Wiltshire.</gtr:impact><gtr:outcomeId>58c19850c485c1.32733066</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>At present the likely impacts are summarised in Other Outputs and Knowledge/Future steps.</gtr:description><gtr:firstYearOfImpact>2013</gtr:firstYearOfImpact><gtr:id>AC15411B-D866-4DA0-8C95-8BD0BA9D0BAD</gtr:id><gtr:impactTypes/><gtr:outcomeId>544d2f64e904d6.38539194</gtr:outcomeId></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>1) Development of mitochondria-targeted iron sensors (to register mitochondrial labile iron) 
We have successfully developed two sets of highly sensitive mitochondria-targeted iron chelators with potential to monitor mitochondrial labile iron levels. The targeting to mitochondria was achieved using the family of mitochondria-homing 'SS-peptides' (short cell-permeant signal peptides mimicking mitochondrial import sequence). The first set are composed of chimaeric iron chelator-peptides of either catechol or hydroxypyridinone type linked to a fluorophore (dansyl, DNS). The second set are composed of mitochondria-targeted peptides incorporating dual fluorescent and selective iron chelators. Both sets were demonstrated to specifically co-localize with mitochondria and their fluorescence emission was found to be sensitive to the presence of iron.
2) Development of mitochondria-targeted iron chelators (to remove elevated mitochondrial labile iron)
We have successfully developed a novel powerful mitochondria-targeted hexadentate tri-catechol-based iron chelator with unprecedented protection against oxidative stress-induced mitochondrial damage and cell death caused by UVA component of sunlight, using cultured primary skin fibroblasts as a cell model.</gtr:description><gtr:exploitationPathways>At present, the mitochondria-targeted iron sensors developed in this project can be used as innovative biological tools to evaluate the impact of mitochondrial labile iron in mitochondria-driven oxidative injurious processes and pathologies. The mitochondria-targeted hexadentate iron chelator developed in this project can also potentially be used for preventive (e.g. skin photoprotection) and therapeutic purposes (e.g. therapy of mitochondrial iron overload diseases such as Friedreich's Ataxia or Parkinson's Disease).</gtr:exploitationPathways><gtr:id>0FE0625F-E5B6-479D-BDAC-E2B6A2C4416E</gtr:id><gtr:outcomeId>544fa03092c788.97642774</gtr:outcomeId><gtr:sectors><gtr:sector>Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors><gtr:url>http://www.sciencedirect.com/science/article/pii/S0022202X16310533</gtr:url></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>In collaboration with Prof RC Hider and as part of an on-going BBSRC grant (BB/J005223/1), we have developed two classes of novel mitochondria-targeted iron sensors that exclusively accumulate in the mitochondria and are capable of registering selectively the mitochondrial labile iron. The first class of compounds consists of mitochondria-homing 'SS' tetra-peptides linked to potent bidentate chelating moieties such as 2-3 dihydroxybenzoic acid and a small fluorescent probe [e.g. alpha-anthraniloyl-L-alpha, beta-diamino propionic acid]. The second generation consists of mitochondria-specific 'SS'-peptides linked to a potent fluorescent bidentate iron chelator.</gtr:description><gtr:id>4B7949E4-8528-4A6E-8795-F18763321772</gtr:id><gtr:impact>The high selectivity of these mitochondria-targeted iron sensors will allow the sensitive evaluation of labile iron distribution in subcellular mitochondrial compartment under physiological and iron-related oxidative and pathological conditions.</gtr:impact><gtr:outcomeId>5442caed34b428.34282178</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Mitochondria-targeted iron sensors</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>In collaboration with Prof RC Hider and as part of the BBSRC grant (BB/J005223/1), we developed one novel mitochondria-targeted iron chelator that exclusively accumulates in the mitochondria and is capable of removing the excess mitochondrial labile iron. This compound consists of mitochondria-homing 'SS' tetra-peptides linked to a potent tri-catechol-based hexadentate chelating moiety. A fluorescent version of this compound was also made by linking the molecule to the dansyl fuorophore.</gtr:description><gtr:id>B0EB7287-BD47-47BD-BDC3-A159C357BEA3</gtr:id><gtr:impact>Both compounds showed unprecedented photoprotective effect in skin cells against ultraviolet A-based mitochondrial damage and the ensuing cell death. such a compound can be added as an ingredient to sunscreen formulations for skin photoprotection against harmful effects of sunlight.</gtr:impact><gtr:outcomeId>56dda96c610a11.41599655</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>mitochondria-targeted iron chelators for mitochondrial labile iron adjustment</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:url>http://dx.doi.org/10.18143/.v6i1</gtr:url></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>AFEC3FE6-AB65-416B-9722-A3E6C5AF94A1</gtr:id><gtr:title>MITOCHONDRIA-TARGETED IRON CHELATORS FOR THE MONITORING AND ADJUSTMENT OF CELLULAR LABILE IRON POOLS</gtr:title><gtr:parentPublicationTitle>AMERICAN JOURNAL OF HEMATOLOGY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf5a7ef67a1954627d1c0e5ca2687c4e"><gtr:id>cf5a7ef67a1954627d1c0e5ca2687c4e</gtr:id><gtr:otherNames>Abbate Vincenzo</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0361-8609</gtr:issn><gtr:outcomeId>56e06ab41274e3.95799667</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>473E9451-83E6-4157-AAC8-40AE796C1E6D</gtr:id><gtr:title>Design of novel fluorescent mitochondria-targeted peptides with iron-selective sensing activity.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/efd2fa24e080eba9dd4b86e024824c70"><gtr:id>efd2fa24e080eba9dd4b86e024824c70</gtr:id><gtr:otherNames>Abbate V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>56dda0ec0512b6.18608507</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9372F17F-67D0-4198-BEC8-3A59BF2D5B51</gtr:id><gtr:title>Design of a Novel Mitochondria-targeted Fluorescent Iron Sensor for the Monitoring of Mitochondrial Labile Iron Pool Level</gtr:title><gtr:parentPublicationTitle>European Iron Club (EIC) Conference 2014</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e698e1f4fb348d5126cea9eab6639514"><gtr:id>e698e1f4fb348d5126cea9eab6639514</gtr:id><gtr:otherNames>Reelfs O, Abbate V, Hider RC, Pourzand C</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>5442ad4e1f91b1.31333370</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>755AA1AF-C069-4F1F-8E88-5DC2F3A6C191</gtr:id><gtr:title>Design of a Novel Mitochondria-targeted Fluorescent Iron Sensor for the Monitoring of Mitochondrial Labile Iron Pool Level.</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/207c83d114a82681cefea447c9d7d19a"><gtr:id>207c83d114a82681cefea447c9d7d19a</gtr:id><gtr:otherNames>Pourzand C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>56e179504151d1.01559493</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E086E287-D10F-4270-A4F3-06667D6F5758</gtr:id><gtr:title>A Powerful Mitochondria-Targeted Iron Chelator Affords High Photoprotection against Solar Ultraviolet A Radiation.</gtr:title><gtr:parentPublicationTitle>The Journal of investigative dermatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a75447fb4f549e7721f5c50a72c64f15"><gtr:id>a75447fb4f549e7721f5c50a72c64f15</gtr:id><gtr:otherNames>Reelfs O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-202X</gtr:issn><gtr:outcomeId>56e172f38eb2d4.14455933</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>07952430-CAD4-4DAB-98EA-7E79FCF0CABD</gtr:id><gtr:title>Novel mitochondria-targeted peptide iron chelators for iron sensing and protection against oxidative stress-induced mitochondrial damage.</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a75447fb4f549e7721f5c50a72c64f15"><gtr:id>a75447fb4f549e7721f5c50a72c64f15</gtr:id><gtr:otherNames>Reelfs O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56e07bdfa7f552.91874026</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A41B75C0-F97E-4503-9D2A-DFCCA7B459CA</gtr:id><gtr:title>Novel mitochondria-targeted peptide iron chelators for iron sensing and protection against oxidative stress-induced mitochondrial damage</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a75447fb4f549e7721f5c50a72c64f15"><gtr:id>a75447fb4f549e7721f5c50a72c64f15</gtr:id><gtr:otherNames>Reelfs O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56ddb5660ab072.74993843</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>81353317-FD1D-4748-9F46-3ABB4FE5E82A</gtr:id><gtr:title>Evaluation of the photoprotective potential of novel hexadentate iron chelators against sunlight-induced damage to skin cells.</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a75447fb4f549e7721f5c50a72c64f15"><gtr:id>a75447fb4f549e7721f5c50a72c64f15</gtr:id><gtr:otherNames>Reelfs O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>56dda3cb0061c7.45743935</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4EB24CE7-5A27-4FAD-AE92-E9D0B0046C90</gtr:id><gtr:title>Iron in biology.</gtr:title><gtr:parentPublicationTitle>Metallomics : integrated biometal science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/efd2fa24e080eba9dd4b86e024824c70"><gtr:id>efd2fa24e080eba9dd4b86e024824c70</gtr:id><gtr:otherNames>Abbate V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1756-5901</gtr:issn><gtr:outcomeId>5aa91621571be9.91155971</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>97FD60F3-2FC7-4884-9A73-978D1B948A3E</gtr:id><gtr:title>Evaluation of the photoprotective potential of novel hexadentate iron chelators against sunlight-induced damage to skin cells.</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a75447fb4f549e7721f5c50a72c64f15"><gtr:id>a75447fb4f549e7721f5c50a72c64f15</gtr:id><gtr:otherNames>Reelfs O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>56e16c8ec33499.94754194</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>55E4BEE6-A304-4ADC-8A89-9AB42448126B</gtr:id><gtr:title>Novel iron chelating probes for the specific monitoring of mitochondrial iron levels.</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/efd2fa24e080eba9dd4b86e024824c70"><gtr:id>efd2fa24e080eba9dd4b86e024824c70</gtr:id><gtr:otherNames>Abbate V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56e07b4a888f35.16976062</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A2916567-60B2-4E1F-A710-CE472015E1B4</gtr:id><gtr:title>The role of labile iron in solar UVA radiation-induced mitochondrial damage-novel mitochondrial sensors and iron chelators for protection</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a75447fb4f549e7721f5c50a72c64f15"><gtr:id>a75447fb4f549e7721f5c50a72c64f15</gtr:id><gtr:otherNames>Reelfs O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58c178027b05f1.46100235</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>01678603-3026-46EB-B3EE-700482BB3F36</gtr:id><gtr:title>Design of novel fluorescent mitochondria-targeted peptides with iron selective sensing activity</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f1921eb23b512a69dd0cf41fa886282"><gtr:id>1f1921eb23b512a69dd0cf41fa886282</gtr:id><gtr:otherNames>Hider R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58c17f9a07e8f3.34869309</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6786CA64-3C63-4864-A43C-FB76C2458A56</gtr:id><gtr:title>Design of novel fluorescent mitochondria-targeted peptides with iron selective sensing activity.</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4cf75bc2ed8b2b080f5ab34593dda5a9"><gtr:id>4cf75bc2ed8b2b080f5ab34593dda5a9</gtr:id><gtr:otherNames>Hider RC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>56e16b6b7bac30.00364242</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5EEC7949-4F9F-408C-9F56-0324DFA8DC3B</gtr:id><gtr:title>Characterisation of a novel hexadentate iron chelator for skin photoprotection.</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a75447fb4f549e7721f5c50a72c64f15"><gtr:id>a75447fb4f549e7721f5c50a72c64f15</gtr:id><gtr:otherNames>Reelfs O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58c19b2aa10246.70936052</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E735D137-192A-4AE4-B413-01B64E434A78</gtr:id><gtr:title>Novel iron chelating probes for the specific monitoring of mitochondrial iron levels. The</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/efd2fa24e080eba9dd4b86e024824c70"><gtr:id>efd2fa24e080eba9dd4b86e024824c70</gtr:id><gtr:otherNames>Abbate V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56ddb64b887d70.17368174</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>054A4A38-B353-409E-9374-F6450EEBC493</gtr:id><gtr:title>Design of novel fluorescent mitochondria-targeted peptides with iron selective sensing activity.</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f1921eb23b512a69dd0cf41fa886282"><gtr:id>1f1921eb23b512a69dd0cf41fa886282</gtr:id><gtr:otherNames>Hider R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>56c363e1002942.40562235</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3BD030A3-27FC-4BE8-B5CF-75CB394C9846</gtr:id><gtr:title>DESIGN OF NOVEL FLUORESCENT MITOCHONDRIA-TARGETED PEPTIDES WITH IRON SELECTIVE SENSING ACTIVITY</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4cf75bc2ed8b2b080f5ab34593dda5a9"><gtr:id>4cf75bc2ed8b2b080f5ab34593dda5a9</gtr:id><gtr:otherNames>Hider RC</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>5640eccda7e657.74355797</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED6E6DA4-0756-4858-89F5-7C55C2157775</gtr:id><gtr:title>Evaluation of the photoprotective potential of novel hexadentate iron chelators against sunlight-induced damage to skin cells.</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a75447fb4f549e7721f5c50a72c64f15"><gtr:id>a75447fb4f549e7721f5c50a72c64f15</gtr:id><gtr:otherNames>Reelfs O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58c181022f6901.06048698</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F5F2B3FC-985E-495B-A981-8773E65A3BA2</gtr:id><gtr:title>Dual selective iron chelating probes with a potential to monitor mitochondrial labile iron pools.</gtr:title><gtr:parentPublicationTitle>Chemical communications (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/efd2fa24e080eba9dd4b86e024824c70"><gtr:id>efd2fa24e080eba9dd4b86e024824c70</gtr:id><gtr:otherNames>Abbate V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1359-7345</gtr:issn><gtr:outcomeId>56c3603324f3b0.66891886</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>76BC209D-64C0-485A-B3D7-DAA5E4490CF9</gtr:id><gtr:title>Mitochondria-targeted iron chelators for the monitoring and adjustment of cellular labile iron pools.</gtr:title><gtr:parentPublicationTitle>Amer. J. Haematol.</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c1ccb10f32aa9c54d8b5f97173d0c332"><gtr:id>c1ccb10f32aa9c54d8b5f97173d0c332</gtr:id><gtr:otherNames>Abbate V, Hider RC, Pourzand C, Reelfs O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>5442abf8458114.62818095</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2D520C6C-BEAA-4B78-857E-26FC61BADCAD</gtr:id><gtr:title>EVALUATION OF THE PHOTOPROTECTIVE POTENTIAL OF NOVEL HEXADENTATE IRON CHELATORS AGAINST SUNLIGHT-INDUCED DAMAGE TO SKIN CELLS</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a75447fb4f549e7721f5c50a72c64f15"><gtr:id>a75447fb4f549e7721f5c50a72c64f15</gtr:id><gtr:otherNames>Reelfs O</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>5640eb145e8d39.51955015</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/J005223/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>F442B6BE-8B89-4C01-8D3B-E8A4D320B672</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Biomolecules &amp; biochemistry</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>A442BF36-F335-483E-9282-F3BB48AC2C47</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Cell biology</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>6FACFC06-C057-4BBC-8936-6881298CB318</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Ageing: chemistry/biochemistry</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>7DA052B9-38AC-4F23-88FA-66C8DEB08B81</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Organelles &amp; components</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>